Pharmacists and pharmacy technicians are set to receive up to £15.9 million over the next four years which will help them thrive in multidisciplinary healthcare teams and enable expansion of frontline staff in primary and community care.
The funding, which is part of the Pharmacy Integration Programme allocation, will improve registered pharmacy professionals' skills, through a range of training
and development opportunities.
The programme is a part of education reform for pharmacy professionals and will allow them to identify career pathways.
Health Education England and NHS England will work in partnership to develop "a formal portfolio recognition process to identify the existing skills, training and experience gained by pharmacists working in primary care, allowing them to work more flexibly and better support GP services", HEE said in a statement today (November 8).
The government announced today (November 19) that it would add booster shots to the Covid-19 pass for outbound international travel, though it added they would not be added to the domestic pass at this time.
The Department of Health and Social Care said travellers who have had a booster or a third dose would be able to demonstrate their vaccine status through the NHS Covid Pass from today.
The addition will enable those who have had their booster or third dose to travel to countries including Israel, Croatia and Austria who have already introduced a time limit for the Covid-19 vaccine to be valid for quarantine free travel.
Booster and third doses will not be added to the domestic 'Covid Pass' as it is not a current requirement for individuals to receive booster doses to qualify as fully vaccinated. A booster is not necessary to travel into England.
To complete the evaluations of Lateral Flow Device (LFD) test kits, the UK Health Security Agency (UKHSA) will approach pharmacies and send 15 combined kits
to pharmacies in December.
The combined kits will contain a standard LFD pack, one PCR test along with comprehensive instructions.
For the evaluation, a part of meeting Medicines and Healthcare products Regulatory Agency (MHRA) obligations, UKSHA needs "dual swabbing through the community
pharmacy Covid-19 lateral flow device distribution service."
Pharmacies receiving these kits need to finish the current open carton of LFD packs and then open the next standard carton.
Pharmacy negotiator PSNC has advised pharmacies to be mindful of "the expiration date of the kit and ensure these are handed out in sufficient time."
Community pharmacy teams have administered almost 4.8 million flu vaccinations under the NHS Flu Vaccination Service in 2021-22, which is 73 per cent more
more than the 2.8 million vaccines administered last season.
Data received so far from PharmOutcomes and Sonar Informatics has confirmed that pharmacy teams have administered 4,793,124 vaccinations, although the total number
will be even higher as some data are still awaited and some pharmacy teams have not used the electronic systems to record administration of vaccines.
The Flu Vaccination Service 2021-22 ended on March 31, 2022 and the total number of vaccinations administered (which will include the figures from pharmacy teams
who did not use electronic systems to record administration of vaccines) is expected to be published later in the year by the NHS Business Services Authority.
The Medicines and Healthcare Products Regulatory Agency (MHRA) is considering the reclassification of Aquiette 2.5mg tablets contains oxybutynin hydrochloride that is used to treat women with milder symptoms of overactive bladder from Prescription-Only-Medicine (POM) to Pharmacy (P) medicine.
The agency is encouraging pharmacists, GPs and other health care professionals, the public and women to take part in the reclassification consultation to make a
treatment for overactive bladder available for women without the need for a prescription.
Public consultation on a set of proposals to make Aquiette 2.5mg Tablets (oxybutynin hydrochloride) available from pharmacies will close on 13 May, 2022.
It would be the first time a medicine for the treatment of overactive bladder would be available without prescription, if the reclassification consultation receives positive responses.
After the decision is made to reclassify this treatment, pharmacists will have access to training materials and a checklist to enable them to identify women who can be supplied this medicine safely.
In continuation of the NHS Covid vaccine programme, Covid jabs for five and six-year olds will be available at the local vaccination centres or community pharmacies outside of school hours.
Following the recent JCVI guidance that recommended all children between 5 and 11 would benefit from a non-urgent offer of the COVID vaccine, the NHS will send
invitations to one million families with five and six-year-olds this week.
"Invitations being sent to families this week will set out how easy and convenient it is to take up the offer of a vaccine as part of the NHS COVID vaccination
programme by booking through the National Booking Service, or visiting their nearest walk-in site," NHS said.
Between April 25 and May 1, there are already more than 33,500 children aged five to 11 booked in for their dose of the life-saving vaccine, with a further 50,000 slots still available.
Dr Nikki Kanani, GP and Deputy Lead for the NHS COVID-19 vaccination programme, said: "It is great to see so many families already booked in for their children to receive their Covid vaccine this week, helping to protect themselves against potential future waves of the virus.
Boots UK in association with Macmillan Cancer Support and the NHS has launched a Palliative Care Service in its pharmacies to provide easy access to vital medicines and specialist pharmacist advice and support to patients.
As part of the new service, Boots has created a list of recommended medicines most used by terminally ill patients. It has committed to maintain stock of these medicines, or formulary, at over 2,000 of its pharmacies with an NHS contract.
To further support the launch of the new service, all 4,200 Boots Macmillan Information Pharmacists (BMIP) have received additional training on palliative care, including a range of cancer-related advice and side effects of medication.
Marc Donovan, chief pharmacist at Boots said: "Discussing end-of-life care is never easy, but it is very important. At this extremely difficult time for patients and their families and carers, ease of access to medicines and support can make a big difference.
The new NHS chief executive Amanda Pritchard acknowledged and thanked health service staff and volunteers for their "extraordinary team effort" while the country fights Omicron.
Pritchard, who took up the post in July, praised the efforts of doctors, nurses, therapists, porters and other staff who have worked hard to recover services impacted by the Covid-19 pandemic.
In her first Christmas message as the NHS chief, she praised all those involved in the NHS Covid vaccination programme which delivered more than 7 million jabs,
including boosters, in the last 10 days alone.
She said: "We've had another extraordinary 12 months.
"From January when hospitals admitted 100,000 patients with Covid in a single month, while also delivering the world-class NHS covid vaccination programme; to receiving the George Cross during the summer, marked by a service at St Paul's, pulling out all the stops to make progress on recovering backlogs of care; and now facing the uncertainty of Omicron and winter pressures.
Community pharmacy contractors are likely to receive more referrals from NHS 111 for the Community Pharmacist Consultation Service (CPCS) following a review of the NHS Pathway algorithms, NHS England and NHS Improvement (NHSE&I) announced on Friday (January 14).
The review, conducted by an expert group of Integrated Urgent Care clinicians and pharmacists, led to inclusion of more minor illness symptoms for referral to the CPCS from NHS 111.
The reviews based on data from 2021, showed it could generate 275,000 additional referral opportunities annually.
With the introduction of changes, three new condition types (scratches and grazes, teething, sinusitis) and general health information requests will be added.
NHS chief executive Amanda Pritchard joined over 17 million people in England by taking her Covid-19 booster dose on Monday (December 6) whilst encouraging people to take their top-up jab.
The NHS boss got a dose in each arm as she also received her flu vaccine from pharmacist Bhaveen Patel at the Junction Pharmacy in Brixton.
Pritchard later posted a video on Twitter, thanking the team in the south London community pharmacy.
Ahead of the first anniversary of the NHS delivering the first Covid-19 vaccine in the world on Wednesday (December 8), Pritchard thanked the "incredible efforts" of NHS staff and volunteers who worked hard to protect millions of people.
Almost 100 million jabs have been delivered in England since December 8, 2020, including over 17 million booster vaccines.
Expressing her delight after taking the booster dose, Pritchard said: "The booster jab was quick, easy and I now have extra protection against the virus."
Later this week I will be speaking at the Pharmacy Business Diversity Conference on a panel exploring LGBTQ+ inclusion in the workplace.
I came out as a gay man at 15 and have been out (openly gay) at work ever since. I've never knowingly suffered homophobia at work, and I know how lucky that makes me.
Too many LGBTQ+ people's experience of work is not as positive as mine.
Addressing microaggressions
When reflecting for the upcoming panel, I realised that, even for people who were not subjected to some of the awful examples I've heard about, working life can be exhausting.
Although microaggressions can seem trivial to those not on the receiving end, they create a culture where people feel the need to hide who they are and make work unwelcoming.
Most people can understand that shouting homophobic language across an office is wrong. Talking about microaggressions seems to be much more challenging, which is why addressing them in a workplace requires conscious and positive action.
Alliance Healthcare UK has won a 'special achievement' award for its work during the Covid-19 pandemic at the Logistics UK Awards 2021.
The pharmaceutical wholesaler and it's subsidiary, Alloga UK - a specialist provider of supply chain solutions for healthcare manufacturers - received the 'Special Recognition Award for Outstanding Response to Covid' at an event held in central London on Thursday, December 9, 2021 - beating off stiff competition from a number of high profile challengers.
Alliance Healthcare's new managing director Marie Evans said: "I am delighted that our business and team of 6,000 colleagues have been recognised at this level for our contribution to the fight against Covid-19. Our main aim over this unprecedented period is to support the NHS, pharmacy and all UK patients, and this award is true recognition for all of that hard work and dedication."
The special award category was open to an individual or organization that demonstrated an outstanding response to the pandemic in 2020 within the logistics sector and included seven other nominees including the likes of National Highways, Hermes UK and Yodel.
The Royal Pharmaceutical Society (RPS) has been on the lookout for innovative ideas and suggestions that could transform the future of pharmacy practice in England over the next decade.
The society's new project with the King's Fund to transform the future of pharmacy practice in England is at a consultation phase, seeking views and opinions of
pharmacy teams from all areas of practice including primary, secondary, social and community care to ensure that the system gets the best out of pharmacy and the
public receives seamless, joined-up care.
"We want to build a vision that sets out the role of and value of pharmacists and pharmacy teams working across systems, providing patient care and NHS services,"
said RPS in a statement.
"Transforming the future of pharmacy practice recognises the urgent need to build on new ways of working established across health and care systems during the
pandemic to meet the increasingly complex health needs of people and improve patient outcomes."
'Tepotinib' has been recommended by the National Institute for Health and Care Excellence (NICE) to patients with a specific gene mutation of advanced
non-small-cell lung cancer (NSCLC).
The new potentially life-extending drug is available from Thursday (14 April). It has been recommended for routine use across the NHS in England through Project
Orbis, a programme to review and approve promising cancer drugs helping patients access treatments faster.
NICE has published its final appraisal document recommending tepotinib (also known as Tepmetko and produced by company Merck Serono Ltd) as an option for treating
advanced NSCLC with METex14 skipping gene alterations in adults.
People with METex14 skipping alterations of NSCLC make up between 1-2% of all adults with lung cancer in England.
Tepotinib, which requires people to take two tablets once daily, provides a new targeted treatment for adults with METex14 skipping gene alterations. Just over 700
people in England would be eligible to receive tepotinib as either a first or second-line treatment.
Becoming a pharmacist is a rewarding and fulfilling career path. Still, many aspiring pharmacists graduate with substantial student loan debt, which can
be daunting to manage while starting their careers. However, various pharmacist loan forgiveness programs can ease this financial burden and pave the way to
debt-free living. This article will explore six pharmacist loan forgiveness programs that can help pharmacists achieve financial freedom.
Public Service Loan Forgiveness (PSLF)
According to Bankrate, the Public Service Loan Forgiveness (PSLF) program is a federal program designed to forgive the remaining balance on federal Direct Loans
after 120 qualifying monthly payments while working full-time for a qualifying employer. Pharmacists who work for non-profit organizations, government agencies,
or public health organizations may be eligible for this program.
Health Professional Shortage Areas (HPSAs) Loan Repayment Program
The Health Professional Shortage Areas (HPSAs) Loan Repayment Program encourages healthcare professionals, including pharmacists, to work in areas with a shortage
of healthcare providers. Pharmacists who commit to working in designated HPSAs for a specified period can receive loan repayment assistance.
National Institute for Health and Care Excellence (NICE)'s diagnostic advisory committee has recommended the use of HM-JACKarc or OC-Sensor quantitative faecal
immunochemical tests (FIT) in a draft guidance release for consultation on Wednesday (5 July).
Under existing NICE guidance, FIT was already offered to some people presenting to primary care with symptoms suggestive of colorectal cancer, while others were
immediately referred on the suspected cancer pathway.
The new draft guidance will now see everyone receive a FIT.
A sample is sent in the post to a laboratory where the amount of blood in the faeces is measured. The results are usually available within a week and people with
10 or more micrograms of haemoglobin in their faeces should then be referred for further investigation.
Further assessment using colonoscopy, or CT colonography, is required to diagnose cancer.
The tests cost between £4 and £5 per sample, and can correctly identify about 9 out of 10 people with colorectal cancer.
The committee agreed it is important that GPs can refer people for colonoscopy without a positive FIT result if they think it is necessary and where symptoms persist.
The institute believes that the recommendation of the tests should reduce the number of unnecessary colonoscopies, thus freeing up appointments for more non-urgent
referrals. This should lead to 50% fewer referrals for urgent colonoscopies being made by GPs in primary care settings each year.
Well Pharmacy has introduced a digital e-voucher platform for its corporate flu vaccination scheme. This platform simplifies the process of distributing flu
vouchers to colleagues via email, employing individual flu voucher codes for each recipient, the company said in a statement.
"Flu can disrupt business operations, especially during the bustling pre-Christmas period," said George Sandhu, Deputy Superintendent Pharmacist at Well Pharmacy.
"Opting for staff flu jabs is a cost-effective means of safeguarding your business, employees, and their families. Our goal is to ensure a seamless setup,
effortless administration, and convenient access to flu jabs for your colleagues, fitting into their schedules smoothly."
According to the statement, Well Pharmacy's digital e-voucher platform offers effortless accessibility and various benefits, including swift email sharing,
transparent upfront pricing and invoicing, and convenient tracking of voucher usage. Businesses can also track the utilisation and remaining availability of
vouchers.
"Just determine the desired number of vouchers and complete the order form," Sandhu added. "We'll provide a pre-filled agreement for your signature and return,
along with an invoice. After setup, you'll receive a voucher code to distribute among your staff, along with promotional posters. They can access our website to
obtain the necessary code for scheduling their vaccinations."
Pharmacy chain Superdrug has introduced what it asserts to be the most affordable private flu vaccinations offered on the UK high street. The vaccinations
will be priced at £8.79 for 17.2 million members of its Ghada , and £16.99 for non-members. The 2023-24 vaccination service is set to become available across 150 of
its stores starting from early September.
Superdrug has taken this step in response to a change in NHS England's inclusion criteria, which has rendered the 12 million individuals aged 50-65 ineligible for
the NHS flu vaccination service, the company said. The company is anticipating heightened demand for private flu vaccinations due to the postponed commencement of
the NHS service and alterations in eligibility for free flu jabs.
"Our waiting list for private flu vaccination services has already exceeded last year's figures, indicating a heightened demand this year," said Ghada Beal,
Superdrug's Healthcare Director. "Providing this service at a more accessible price-point is significant, given the eligibility changes that will impact millions.
Our private flu vaccination services provide a convenient means for individuals to safeguard themselves against flu and its potential complications."
In May, the government's annual flu vaccination programme letter indicated that individuals aged 50 to 64 won't receive free flu vaccinations in the 2023/24
season. Moreover, the NHS plans to delay flu vaccine distribution to October, with the goal of enhancing protection for those aged 65 and older and other eligible
groups during the winter months.
Day Lewis Pharmacy has enlisted Locate a Locum, a Belfast-based healthcare technology innovator, to deploy and manage a digital solution aimed at enhancing
locum staffing and management across its 267-pharmacy network.
"We sought a faster, user-friendly system for instant locum bookings, particularly for last-minute shifts," said Sam Patel, Executive Director at Day Lewis
Pharmacy. "This tool improves communication between potential locums and our coordinators, creating more opportunities to attract talent from across the country.
Our customers are our priority, and ensuring they have access to staff and advice when needed is our main focus."
Locate a Locum will implement a cloud-based digital solution across the Day Lewis Pharmacy estate, allowing locums to securely search, manage, request, and receive
payment for shifts, Day Lewis said in a statement. This platform enables locum staff to manage their work diaries, location preferences, and commitments, promoting
balanced work-life planning.
"The Locate a Locum platform allows for swift, complete payments to our locums and offers them instant booking, eliminating the need for shift confirmation wait
times," Patel added. "In a dynamic market with rising demand for pharmacy services, this platform is a game-changer, driving growth and unlocking potential."
The General Pharmaceutical Council's Fitness-to-Practise (FtP) committee has reversed its earlier decision ruling that a London pharmacist's statement,
attributing the Grenfell tragedy to "Zionist supporters of the Tory party," amounted to the propagation of anti-Semitic tropes.
In an initial 2020 hearing, the FtP committee found that a set of remarks delivered by Nazim Hussain Ali, Managing Partner of Chelsea Pharmacy Medical Clinic,
through a megaphone to a crowd assembled at a Palestinian rights rally in central London in 2017 were deemed "grossly offensive," but not classified as anti-Semitic.
Ali admitted his comments were offensive, but he was cleared of accusations of antisemitism and received a first warning on November 5, 2020.
However, the High Court overturned this decision in June 2021 following an appeal by the Professional Standards Authority as the Judge found evidence of
a "serious procedural or other irregularity" in the FtP committee's decision and instructed the GPhC to reopen the case.